March 26, 2012
The generic version of the hyperlipidemia treatment Epadel, marketed by Sawai Pharmaceutical and Nichi-Iko Pharmaceutical, has been in short supply since the 2010 revision of medical fees due to shortages in drug substances. The demands for the Epadel generic have...read more